ORAL ABSTRACT: MPN-099: Restore-PV: A Phase 2 Open-Label Study Evaluating the Safety and Efficacy of the Anti-TMPRSS6 Monoclonal Antibody DISC-3405 in Participants with Polycythemia Vera
Year: 2026
Type: article
Authors: Naseema Gangat, Ayalew Tefferi, Aaron T Gerds, Michael Grunwald, Anna B Halpern, Stephen Oh, Caitlin O'Neill, Jeanne Palmer, Lindsay Rein, Candido Rivera, Gary Schiller, Joseph Shatzel, Lynn Guiducci, Jennifer Vaughn, Anne Wofford, Shuai Chen, Alison Kracunas, Marcus Carden, Will Savage, Prithviraj Bose, Naveen Pemmaraju
Institutions: Mayo Clinic, Cleveland Clinic, Levine Cancer Institute, University of Washington, Fred Hutch Cancer Center, Washington University in St. Louis, USC Norris Comprehensive Cancer Center, Mayo Clinic Hospital, Duke University, Mayo Clinic in Florida, University of California, Los Angeles, Oregon Health & Science University, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Atrium Health Wake Forest Baptist, Disc Medicine, Inc. (United States), The University of Texas MD Anderson Cancer Center
Language: English
Subfield: Genetics (clinical)
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7204687909